Mochida Pharmaceutical Co.,Ltd. Logo

Mochida Pharmaceutical Co.,Ltd.

An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.

4534 | T

Overview

Corporate Details

ISIN(s):
JP3922800002
LEI:
Country:
Japan
Address:
新宿区四谷一丁目7番地
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Mochida Pharmaceutical Co., Ltd. is a research and development-driven company engaged in the manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. The company's core pharmaceutical business focuses on developing innovative drugs in targeted therapeutic areas, including cardiovascular medicine, obstetrics and gynecology, psychiatry, and gastroenterology. Its operations span from R&D and manufacturing of various formulations, such as injectables and oral solids, to marketing and sales. In addition to its prescription drug portfolio, Mochida also develops and provides skincare and other healthcare-related products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 05:14
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-11-10 05:12
Interim Report
半期報告書-第88期(2025/04/01-2026/03/31)
Japanese 195.0 KB
2025-07-01 03:25
Regulatory News Service
臨時報告書
Japanese 28.8 KB
2025-06-27 06:50
Registration Form
確認書
Japanese 8.7 KB
2025-06-27 06:49
Governance Information
内部統制報告書-第87期(2024/04/01-2025/03/31)
Japanese 24.7 KB
2025-06-27 06:43
Registration Form
有価証券報告書-第87期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2024-11-11 01:36
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-11-11 01:35
Interim Report
半期報告書-第87期(2024/04/01-2025/03/31)
Japanese 192.6 KB
2024-06-28 06:36
Post-Annual General Meeting Information
臨時報告書
Japanese 28.0 KB
2024-06-27 07:03
Registration Form
確認書
Japanese 8.7 KB
2024-06-27 07:02
Governance Information
内部統制報告書-第86期(2023/04/01-2024/03/31)
Japanese 23.5 KB
2024-06-27 07:01
Annual Report
有価証券報告書-第86期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2024-02-13 02:30
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-02-13 02:29
Quarterly Report
四半期報告書-第86期第3四半期(2023/10/01-2023/12/31)
Japanese 161.3 KB
2023-11-13 01:38
Regulatory News Service
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Mochida Pharmaceutical Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mochida Pharmaceutical Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mochida Pharmaceutical Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany
BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia
BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland
BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom
BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland
BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden
BIOVIC
BIOVIE INC. Logo
Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
AI-driven biopharma developing treatments for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology drugs targeting mutation families in lung and brain cancers.
United States of America
BDTX
BL Pharmtech Corp. Logo
Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.
South Korea
065170

Talk to a Data Expert

Have a question? We'll get back to you promptly.